Related Experiment Video
Updated: Jul 18, 2026
08:17
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
Nucleic acid therapeutics for hematologic malignancies--theoretical considerations.
Joanna B Opalinska1, Anna Kalota, Jyoti Chattopadhyaya
1Pommeranian Medical Academy, 71245 Szczecin, Poland.
Annals of the New York Academy of Sciences
|December 6, 2006
Summary
Developing RNA targeted gene silencing agents like antisense nucleic acids (ASNAs) requires optimization for drug efficacy in hematologic malignancies. Our review details strategies to improve delivery, targeting, and mRNA destruction for practical nucleic acid therapeutics.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- RNA targeted gene silencing agents, including antisense oligodeoxynucleotides (AS ODNs) and short interfering RNA (siRNA), show promise for sequence-specific gene expression perturbation.
- Clinical applications of antisense nucleic acids (ASNAs) are limited by challenges in intracellular delivery, targeting, chemical composition, and mRNA destruction efficiency.
Purpose of the Study:
- To review recent work focused on optimizing ASNAs for effective treatment of hematologic malignancies.
- To address critical issues hindering the development of practical and effective nucleic acid drugs.
Main Methods:
- Review of experimental systems demonstrating sequence-specific gene silencing.
- Analysis of clinical experiences and challenges with current ASNA technologies.
- Overview of strategies to enhance intracellular delivery, targeting, chemical modification, and mRNA degradation.
Main Results:
- Identified key areas for ASNA optimization: intracellular delivery, targeting, chemical composition, and mRNA destruction efficiency.
- Highlighted the potential of optimized ASNAs to overcome limitations in current gene silencing therapies.
- Presented a framework for developing practical and effective nucleic acid-based drugs.
Conclusions:
- Optimizing ASNAs is crucial for developing effective drugs against hematologic malignancies.
- Addressing delivery, targeting, chemical properties, and mRNA destruction will enable practical nucleic acid therapeutics.
- Further research and development in ASNA optimization hold significant promise for cancer treatment.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...